Calcium Hydroxylapatite Caha
Ingredient: 26mg/ml HA, Hydroxyapatite 30%
Specification: 1ml
Package: Single package
Application Area: Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc.
Product Introduction:
The product’s elevated sodium hyaluronate content ensures an instant firming effect and natural results from the first injection. Additionally, the hydroxyapatite microspheres have a highly porous structure, significantly increasing the surface area for fibroblast interactions. This improves protein and cell attachment, boosting the chances of self-growth factor accumulation.
Product Display:
Product Details:
Type | |
Ingredient | Hyaluronic 26mg/ml, hydroxyapatite 30% |
Specification | 1ml |
Effect area | Subcutaneous injection |
Application area | Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12-24 months |
Lasting time | 18-24 months |
Microsphere size | 25-45μm |
Extruding force | 23N (27G thin-walled needle) |
Product Package:
Customer Feedback:
Raw Material Advantages:
Deeply penetrating the dermis, sodium hyaluronate swiftly revitalizes the skin, providing an instant lifting and firming effect. Hydroxyapatite plays a crucial role in stimulating collagen fiber production, effectively restoring the skin’s internal structure and facilitating the natural regeneration of collagen. Over time, a dense and refined collagen structure forms, ensuring long-term lifting results.
In comparison to major American brands, our product contains a higher sodium hyaluronate concentration of 24-26mg/ml, ensuring an immediate firming and natural effect post-injection. Moreover, the hydroxyapatite microspheres in our formula exhibit high porosity, increasing their interaction surface with fibroblasts. This supports better protein and cell adhesion, enhancing the accumulation of self-growth factors.
Development Process:
Company Introduction:
Our synthesis and purification technology ensures that PCL/PLLA meets medical-grade standards with low tin content (Sn <30 ppm), a regulated molecular weight, and excellent biocompatibility, supported by self-developed synthesis equipment capable of anhydrous, oxygen-free, kilogram-scale production. Simultaneously, our industrial-grade purification process refines raw materials into sterile, pyrogen-free medical-grade substances, including sodium hyaluronate, carboxymethyl starch, and carboxymethyl cellulose.